Abstract Background [18F]Fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) is recommended during diagnostic work-up for ovarian cancer; however. [18F]FDG PET has several inherent limitations. The novel oncologic PET-tracer fibroblast activation protein inhibitor (FAPI) has demonstrated promising results in multiple cancer types. including ovarian cancer. https://qnldcjvl8u6pwo.timeblog.net/70685866/policy-responses-to-the-covid-19-pandemic-in-the-manitoba-grocery-sector-a-qualitative-analysis-of-media-organizational-communications-and-key-informant-interviews